This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Under $10 Moving Higher


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Endocyte (ECYT - Get Report) is a biopharmaceutical company. Endocyte is engaged in developing therapies for the treatment of cancer and inflammatory diseases. This stock is trading up 12.2% at $5.50 in recent trading.

Today's Range: $4.93-$5.78

52-Week Range: $3.02-$14.80

Volume: 2.2 million

Three-Month Average Volume: 867,048

>>7 Cancer Drug Stocks to Know Right Now

From a technical perspective, ECYT is ripping higher today off some near-term previous support at $4.83 with monster volume. This move is quickly pushing ECYT within range of triggering a big breakout. That breakout will trigger once ECYT takes out some near-term overhead resistance at $6.48 with volume.

Traders should now look for long-biased trades if EYCT can sustain a high-volume move and close over $6.48. Look for volume on that move that's near or well above 867,048 shares. If we get that action soon, then look for ECYT to make a run at its 200-day moving average of $8.68 in the near future.
3 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ZLCS $5.39 0.00%
ACUR $2.21 2.30%
ACAD $17.94 2.20%
ECYT $2.99 2.40%
GALE $0.77 1.80%


Chart of I:DJI
DOW 15,893.71 +233.53 1.49%
S&P 500 1,847.89 +18.81 1.03%
NASDAQ 4,294.0220 +27.1850 0.64%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs